On this page you will find any clinical guidance and treatment pathways that have been approved by GMMMG or its Subgroups.
Documents are listed alphabetically.
The ‘Document Title’, ‘Issue Date’ and ‘Review Date’ headings below are active links. Click a heading to sort in ascending or descending order.
|Engagement with the Pharmaceutical Industry
|GMMMG Appeals Policy
|Guidelines for defining Red, Amber, Green, DNP and Grey status
|High cost drug business case template
|High cost drugs service development guideline
|Management of Red Listed drugs in primary care
|Primary care rebate schemes
|Safe Management of Medicines within GP Practices